Statin Intolerance in Patients With Myocardial Infarction

Overview

Patients with acute coronary syndrome (MI, NSTEMI, USAP) will be included. They will be screened for statin intolernace for 6 months.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 2, 2020

Interventions

  • Diagnostic Test: Statin intolerance test
    • Statin intolerance test

Clinical Trial Outcome Measures

Primary Measures

  • Statin intolerance
    • Time Frame: 6 months
    • Number (percentage) of patients with statin intolerance

Participating in This Clinical Trial

Inclusion Criteria

  • Acute coronary syndrome Exclusion Criteria:

  • Being on statin, having statin related side effects

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Turkish Society of Cardiology
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.